PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT
Date
2018Author
Faivre-Finn, C.
Ozguroglu, M.
Villegas, A.
Daniel, D.
Murakami, S.
Hui, R.
Lee, K.
Cho, B. C.
Kubota, K.
Poole, L.
Wadsworth, C.
Dennis, P.
Antonia, S.
Vansteenkiste, J.
Naidoo, J.
Metadata
Show full item recordCollections
- Makale [92796]